CVE-2022-38512

CVE-2022-38512 is a medium-severity improper privilege management vulnerability in com.liferay:com.liferay.translation.web (maven), affecting versions < 2.0.58. It is fixed in 2.0.58, 7.4.13.u37.

Does this CVE actually affect you?

Kodem shows which CVEs are reachable and running in your applications, so you fix what's exploitable, not just what's listed.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Runtime intelligence, not another scanner.

Summary

Liferay Portal and Liferay DXP Fails to Check Permissions in Translation Module

The Translation module before v2.0.58 from Liferay Portal (v7.4.3.12 through v7.4.3.36), and Liferay DXP 7.4 update 8 through 36 does not check permissions before allowing a user to export a web content for translation, allowing attackers to download a web content page's XLIFF translation file via crafted URL.

Impact

The application assigns, modifies, tracks, or checks privileges incorrectly, allowing a user to gain elevated access. Typical impact: privilege escalation beyond the intended level.

CVE-2022-38512 has a CVSS score of 6.5 (Medium). The vector is network-reachable, no privileges required, and user interaction required. A CVSS score reflects the worst-case severity of the vulnerability, not your specific exposure. Whether this affects your application depends on whether the vulnerable code is present and reachable in your environment. A fixed version is available (2.0.58, 7.4.13.u37); upgrading removes the vulnerable code path.

Affected versions

com.liferay:com.liferay.translation.web (< 2.0.58) com.liferay.portal:release.dxp.bom (>= 7.4.13.u8, <= 7.4.13.u36)

Security releases

com.liferay:com.liferay.translation.web → 2.0.58 (maven) com.liferay.portal:release.dxp.bom → 7.4.13.u37 (maven)

Kodem intelligence

Severity tells you how bad this could be in the worst case. It does not tell you whether you are exposed. Exploitability and impact are functions of runtime truth: whether the vulnerable code is present, reachable, and actually executes in your application. A vulnerable package can sit in your dependency tree and never run.

Kodem, an Intelligent Application Security platform, uses runtime intelligence to reveal which vulnerabilities actually execute in production, so teams prioritize the ones that genuinely matter. Kodem's runtime-powered SCA identifies whether this CVE is reachable in your applications.

Already deployed Kodem?

See it in your environmentNew to Kodem? Get a demo →

Remediation advice

Upgrade the following packages to resolve this vulnerability:

com.liferay:com.liferay.translation.web to 2.0.58 or later; com.liferay.portal:release.dxp.bom to 7.4.13.u37 or later

Kodem Kai can prioritize this vulnerability in your dependency tree and generate a fix recommendation.

Frequently Asked Questions

  1. What is CVE-2022-38512? CVE-2022-38512 is a medium-severity improper privilege management vulnerability in com.liferay:com.liferay.translation.web (maven), affecting versions < 2.0.58. It is fixed in 2.0.58, 7.4.13.u37. The application assigns, modifies, tracks, or checks privileges incorrectly, allowing a user to gain elevated access.
  2. How severe is CVE-2022-38512? CVE-2022-38512 has a CVSS score of 6.5 (Medium). This score reflects the worst-case severity of the vulnerability, not your specific exposure. Whether it represents real risk in your environment depends on whether the vulnerable code is present and reachable.
  3. Which packages are affected by CVE-2022-38512?
    • com.liferay:com.liferay.translation.web (maven) (versions < 2.0.58)
    • com.liferay.portal:release.dxp.bom (maven) (versions >= 7.4.13.u8, <= 7.4.13.u36)
  4. Is there a fix for CVE-2022-38512? Yes. CVE-2022-38512 is fixed in 2.0.58, 7.4.13.u37. Upgrade to this version or later.
  5. Is CVE-2022-38512 exploitable, and should I be worried? Whether CVE-2022-38512 is exploitable in your environment depends on whether the vulnerable code is present and reachable. A CVSS score is a worst-case rating; it does not account for your specific deployment, configuration, or usage patterns. Kodem, an Intelligent Application Security platform, uses runtime intelligence to show which vulnerabilities actually execute in production, so you can focus on the ones that represent real risk. Get a demo
  6. What actually determines whether CVE-2022-38512 is exploitable, and how bad it is? Exploitability and impact are not fixed properties of a CVE. They depend on runtime truth: whether the vulnerable code is present, reachable, and actually executes in your application. A high CVSS score on a dependency that never runs is not the same as real risk. Kodem, an Intelligent Application Security platform, uses runtime intelligence to reveal which vulnerabilities actually execute in production, so teams prioritize the ones that genuinely matter.
  7. How do I fix CVE-2022-38512?
    • Upgrade com.liferay:com.liferay.translation.web to 2.0.58 or later
    • Upgrade com.liferay.portal:release.dxp.bom to 7.4.13.u37 or later

Other vulnerabilities in com.liferay:com.liferay.translation.web

Stop the waste.
Protect your environment with Kodem.